Remegen Co., Ltd.

This study tests an investigational drug called telitacicept in 260 adults with lung scarring caused by connective tissue diseases like rheumatoid arthritis or lupus. The goal is to see if the drug can slow the decline in lung volume compared to a placebo over one year, while pat…

This study compares a new drug, RC148, combined with chemotherapy against the standard treatment (bevacizumab plus chemotherapy) for people with advanced colorectal cancer that cannot be removed by surgery or has spread. The goal is to see if RC148 works better at shrinking tumor…

This study tests a new drug called RC288 in people with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to find a safe dose and see if the drug can shrink tumors. About 326 adults aged 18 to 75 with good overall health may join.